Company Overview
| Stock Name | Uni Health |
|---|---|
| Stock Code | 02211 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 我們為中國東北地區領先的醫藥零售商及分銷商,擁有中國東北地區最大的醫藥零售連鎖網絡,並為中國東北地區最大的民營醫藥分銷商 |
| Listing Date | 2013-12-12 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國瀋陽鐵西區保工北街15號 |
| Business Address (Hong Kong) | 香港皇后大道中15號置地廣場告羅士打大廈8樓 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | jtyyjt.com |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 2.91 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2013-12-02 to 2013-12-05 |
| Global Offering Shares | 500,000,000 shares |
| HK Public Offer Shares (Initial) | 50,000,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 450,000,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 1,999,999,999 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 1,455,000,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| HK Market Cap | HK$ 411.9M |
| Est. Threshold | HK$ 9.37B |
| Analysis Result | HK market cap below threshold, need +2175% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約人民幣228百萬元 |
| Period-End Cash Balance | 人民幣455.9百萬元 |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2010 | 2011 | 2012 | 2013-06 |
|---|---|---|---|---|
| Revenue | 858,613 | 1,473,902 | 2,326,292 | 1,456,990 |
| Cost of sales | -618,872 | -1,095,758 | -1,780,523 | -1,073,274 |
| Gross profit | 239,741 | 378,144 | 545,769 | 383,716 |
| Other income and gains, net | 2,209 | 482 | 1,122 | 28 |
| Selling and distribution expenses | -67,323 | -103,010 | -188,887 | -137,763 |
| Administrative expenses | -11,625 | -30,743 | -41,974 | -30,248 |
| Operating profit | 160,916 | 244,848 | 301,755 | 214,497 |
| Net finance costs | -34 | -79 | -188 | -157 |
| Share of associates and JVs | 0 | 632 | 1,137 | 808 |
| Profit before tax | 163,605 | 251,223 | 305,880 | 217,573 |
| Income tax expense | -41,095 | -62,377 | -78,517 | -53,527 |
| Profit for the year | 122,510 | 188,846 | 227,363 | 164,046 |
| Profit attributable to owners | 122,510 | 180,117 | 213,760 | 150,780 |
Balance Sheet
| Item | 2010 | 2011 | 2012 | 2013-06 |
|---|---|---|---|---|
| Cash and cash equivalents | 107,025 | 713,257 | 455,916 | 592,868 |
| Trade and bills receivables | 75,281 | 209,579 | 273,730 | 237,111 |
| Inventories | 80,593 | 177,929 | 249,442 | 270,879 |
| Total current assets | 262,899 | 1,100,765 | 1,098,520 | 1,109,125 |
| Total assets | 268,830 | 1,232,769 | 1,515,146 | 1,657,421 |
| Total current liabilities | 81,718 | 826,960 | 862,119 | 860,975 |
| Total liabilities | 81,718 | 831,525 | 886,988 | 884,915 |
| Total equity | 187,112 | 401,244 | 628,158 | 772,506 |
| Equity attributable to owners | 187,112 | 362,457 | 548,781 | 688,313 |
Cash Flow Statement
| Item | 2010 | 2011 | 2012 | 2013-06 |
|---|---|---|---|---|
| Net cash from operating activities | 107,378 | 121,795 | 161,628 | 170,225 |
| Net cash from investing activities | 35,534 | -179,022 | -323,421 | -34,222 |
| Net cash from financing activities | -105,834 | 663,799 | -95,531 | 2,061 |
| Net increase in cash | 37,078 | 606,572 | -257,324 | 138,064 |
| Purchase of PP&E | -1,030 | -11,742 | -14,537 | -38,023 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 2.37 |
|---|---|
| First Day Open | HK$ 1.99 |
| First Day Change | -18.56% |
| First Day Volume | 208939000.0 |
| First Day Turnover | 515674000.0 |
| Use of Proceeds | (1) 所得款項凈額約40%將用作為我們于中國(尤其中國東北地區)收購擴張提供資金。截至最后實際可行日期,我們并無物色到任何收購對象;
(2) 所得款項凈額約30%將用作為我們的內生增長提供資金,內生增長包括新設藥店以及升級我們現有的物流中心及額外設立物流中心;
(3) 所得款項凈額約20%將用作推廣金天愛心、授權品牌及授權品牌產品。根據本集團所
采用的價值鏈整合模式,授權品牌產品相關的推廣和營銷工作通常由分銷商(而非制造商)進行,因為分銷商能夠直接接觸下游客戶。
(4) 所得款項凈額約10%將用作營運資金。 |
Underwriting Syndicate
Sole Sponsor (1)
Morgan Stanley Asia Limited CE AAD291
Overall Coordinators (1)
Morgan Stanley Asia Limited CE AAD291
Joint Bookrunners (3)
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 金東濤 | — |
| Company Secretary | 葛俊明、翁美儀 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 最終控股股東為金先生 |
|---|




